The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer
Abstract
BACKGROUND: Postoperative complications, especially pulmonary complications, affect more than half the patients who undergo open esophagectomy for esophageal cancer. Whether hybrid minimally invasive esophagectomy results in lower morbidity than open esophagectomy is unclear. METHODS: We performed a multicenter, open-label, randomized, controlled trial involving patients 18 to 75 years of age with resectable cancer of the middle or lower third of the esophagus. Patients were randomly assigned to undergo transthoracic open esophagectomy (open procedure) or hybrid minimally invasive esophagectomy (hybrid procedure). Surgical quality assurance was implemented by the credentialing of surgeons, standardization of technique, and monitoring of performance. Hybrid surgery comprised a two-field abdominal-thoracic operation (also called an Ivor-Lewis procedure) with laparoscopic gastric mobilization and open right thoracotomy. The primary end point was intraoperative or postoperative complication of grade II or higher according to the Clavien-Dindo classification (indicating major complication leading to intervention) within 30 days. Analyses were done according to the intention-to-treat principle. RESULTS: From October 2009 through April 2012, we randomly assigned 103 patients to the hybrid-procedure group and 104 to the open-procedure group. A total of 312 serious adverse events were recorded in 110 patients. A total of 37 patients (36%) in the hybrid-procedure group had a major intraoperative or postoperative complication, as compared with 67 (64%) in the open-procedure group (odds ratio, 0.31; 95% confidence interval [CI], 0.18 to 0.55; P<0.001). A total of 18 of 102 patients (18%) in the hybrid-procedure group had a major pulmonary complication, as compared with 31 of 103 (30%) in the open-procedure group. At 3 years, overall survival was 67% (95% CI, 57 to 75) in the hybrid-procedure group, as compared with 55% (95% CI, 45 to 64) in the open-procedure group; disease-free survival was 57% (95% CI, 47 to 66) and 48% (95% CI, 38 to 57), respectively. CONCLUSIONS: We found that hybrid minimally invasive esophagectomy resulted in a lower incidence of intraoperative and postoperative major complications, specifically pulmonary complications, than open esophagectomy, without compromising overall and disease-free survival over a period of 3 years. (Funded by the French National Cancer Institute; ClinicalTrials.gov number, NCT00937456 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dindo, D., Demartines, N., & Clavien, P.-A. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000133083.54934.ae · Cited by 31,378
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
van Hagen, P., Hulshof, M. C. C. M., van Lanschot, J. J. B., Steyerberg, E. W., Henegouwen, M. I. V. B., Wijnhoven, B. P. L., Richel, D. J., Nieuwenhuijzen, G. A. P., Hospers, G. A. P., Bonenkamp, J. J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112088 · Cited by 5,521
Hospital Volume and Surgical Mortality in the United States
Birkmeyer, J. D., Siewers, A. E., Finlayson, E. V. A., Stukel, T. A., Lucas, F. L., Batista, I., Welch, H. G., & Wennberg, D. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa012337 · Cited by 4,999
Lacy, A. M., García-Valdecasas, J. C., Delgado, S., Castells, A., Taurá, P., Piqué, J. M., & Visa, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09290-5 · Cited by 2,441
Biere, S. S., van Berge Henegouwen, M. I., Maas, K. W., Bonavina, L., Rosman, C., Garcia, J. R., Gisbertz, S. S., Klinkenbijl, J. H., Hollmann, M. W., de Lange, E. S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60516-9 · Cited by 1,710
van der Pas, M. H., Haglind, E., Cuesta, M. A., Fürst, A., Lacy, A. M., Hop, W. C., & Bonjer, H. J. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70016-0 · Cited by 1,707
Bosset, J.-F., Gignoux, M., Triboulet, J.-P., Tiret, E., Mantion, G., Elias, D., Lozach, P., Ollier, J.-C., Pavy, J.-J., Mercier, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370304 · Cited by 1,376
Cancers with increasing incidence trends in the United States: 1999 through 2008
Simard, E. P., Ward, E. M., Siegel, R., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20141 · Cited by 724
Kim, W., Kim, H.-H., Han, S.-U., Kim, M.-C., Hyung, W. J., Ryu, S. W., Cho, G. S., Kim, C. Y., Yang, H.-K., Park, D. J., et al. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001346 · Cited by 630
Cited by
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Obermannová, R., Alsina, M., Cervantes, A., Leong, T., Lordick, F., Nilsson, M., van Grieken, N. C. T., Vogel, A., & Smyth, E. C. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.07.003 · Cited by 730
Recent progress in multidisciplinary treatment for patients with esophageal cancer
Watanabe, M., Otake, R., Kozuki, R., Toihata, T., Takahashi, K., Okamura, A., & Imamura, Y. (2020) · Surgery Today · doi:10.1007/s00595-019-01878-7 · Cited by 428
Yang, H., Wang, F., Hallemeier, C. L., Lerut, T., & Fu, J. (2024) · The Lancet · doi:10.1016/s0140-6736(24)02226-8 · Cited by 299
Metadata
- Authors
- Mariette, C., Markar, S. R., Dabakuyo-Yonli, T. S., Meunier, B., Pezet, D., Collet, D., D’Journo, X. B., Brigand, C., Perniceni, T., Carrère, N., Mabrut, J.-Y., Msika, S., Peschaud, F., Prudhomme, M., Bonnetain, F., & Piessen, G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2019-01-10
- Volume
- 380
- Issue
- 2
- Pages
- 152-162
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2910703056
- Cited by
- 725
- References
- 18
- FWCI
- 87.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer. https://app.cochat.ai/papers/10.1056/nejmoa1805101
- The paper
- Mariette, C., Markar, S. R., Dabakuyo-Yonli, T. S., Meunier, B., Pezet, D., Collet, D., D’Journo, X. B., Brigand, C., Perniceni, T., Carrère, N., Mabrut, J.-Y., Msika, S., Peschaud, F., Prudhomme, M., Bonnetain, F., & Piessen, G. (2019). Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1805101
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.